Clinical trial
Evaluating the Use of Acute Intermittent Hypoxia to Improve Symptoms in Persons With Multiple Sclerosis
NCT04280484 is registered in ClinicalTrials.gov with Shirley Ryan AbilityLab as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Use of Acute Intermittent Hypoxia to Improve Symptoms in Persons With Multiple Sclerosis
- Lead sponsor
- Shirley Ryan AbilityLab
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 18, 2018
- Completion date
- December 30, 2019
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.